nodes	percent_of_prediction	percent_of_DWPC	metapath
Ipratropium bromide—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0824	0.216	CbGbCtD
Ipratropium bromide—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0625	0.164	CbGbCtD
Ipratropium bromide—CYP3A4—Betamethasone—ankylosing spondylitis	0.0536	0.14	CbGbCtD
Ipratropium bromide—CYP3A4—Prednisolone—ankylosing spondylitis	0.0529	0.139	CbGbCtD
Ipratropium bromide—CYP3A4—Prednisone—ankylosing spondylitis	0.05	0.131	CbGbCtD
Ipratropium bromide—CYP2D6—Dexamethasone—ankylosing spondylitis	0.049	0.128	CbGbCtD
Ipratropium bromide—CYP3A4—Dexamethasone—ankylosing spondylitis	0.0312	0.0817	CbGbCtD
Ipratropium bromide—Epistaxis—Triamcinolone—ankylosing spondylitis	0.00211	0.00342	CcSEcCtD
Ipratropium bromide—Visual impairment—Prednisolone—ankylosing spondylitis	0.00211	0.00341	CcSEcCtD
Ipratropium bromide—Haemoglobin—Triamcinolone—ankylosing spondylitis	0.00202	0.00327	CcSEcCtD
Ipratropium bromide—Haemoglobin—Methylprednisolone—ankylosing spondylitis	0.00202	0.00326	CcSEcCtD
Ipratropium bromide—Rhinitis—Triamcinolone—ankylosing spondylitis	0.00201	0.00326	CcSEcCtD
Ipratropium bromide—Rhinitis—Methylprednisolone—ankylosing spondylitis	0.00201	0.00325	CcSEcCtD
Ipratropium bromide—Haemorrhage—Triamcinolone—ankylosing spondylitis	0.00201	0.00325	CcSEcCtD
Ipratropium bromide—Haemorrhage—Methylprednisolone—ankylosing spondylitis	0.00201	0.00324	CcSEcCtD
Ipratropium bromide—Pharyngitis—Triamcinolone—ankylosing spondylitis	0.00199	0.00323	CcSEcCtD
Ipratropium bromide—Neuropathy peripheral—Dexamethasone—ankylosing spondylitis	0.00199	0.00322	CcSEcCtD
Ipratropium bromide—Neuropathy peripheral—Betamethasone—ankylosing spondylitis	0.00199	0.00322	CcSEcCtD
Ipratropium bromide—Conjunctivitis—Dexamethasone—ankylosing spondylitis	0.00197	0.00319	CcSEcCtD
Ipratropium bromide—Conjunctivitis—Betamethasone—ankylosing spondylitis	0.00197	0.00319	CcSEcCtD
Ipratropium bromide—Visual impairment—Methylprednisolone—ankylosing spondylitis	0.00193	0.00313	CcSEcCtD
Ipratropium bromide—Eye disorder—Methylprednisolone—ankylosing spondylitis	0.00187	0.00303	CcSEcCtD
Ipratropium bromide—Cardiac disorder—Methylprednisolone—ankylosing spondylitis	0.00186	0.00301	CcSEcCtD
Ipratropium bromide—Haemoglobin—Dexamethasone—ankylosing spondylitis	0.00183	0.00296	CcSEcCtD
Ipratropium bromide—Haemoglobin—Betamethasone—ankylosing spondylitis	0.00183	0.00296	CcSEcCtD
Ipratropium bromide—Haemorrhage—Dexamethasone—ankylosing spondylitis	0.00182	0.00295	CcSEcCtD
Ipratropium bromide—Haemorrhage—Betamethasone—ankylosing spondylitis	0.00182	0.00295	CcSEcCtD
Ipratropium bromide—Immune system disorder—Methylprednisolone—ankylosing spondylitis	0.00181	0.00293	CcSEcCtD
Ipratropium bromide—Mediastinal disorder—Methylprednisolone—ankylosing spondylitis	0.00181	0.00292	CcSEcCtD
Ipratropium bromide—Vision blurred—Prednisolone—ankylosing spondylitis	0.00179	0.0029	CcSEcCtD
Ipratropium bromide—Visual impairment—Betamethasone—ankylosing spondylitis	0.00176	0.00284	CcSEcCtD
Ipratropium bromide—Visual impairment—Dexamethasone—ankylosing spondylitis	0.00176	0.00284	CcSEcCtD
Ipratropium bromide—Angioedema—Prednisolone—ankylosing spondylitis	0.00174	0.00281	CcSEcCtD
Ipratropium bromide—Neuropathy peripheral—Prednisone—ankylosing spondylitis	0.00173	0.0028	CcSEcCtD
Ipratropium bromide—Dysgeusia—Triamcinolone—ankylosing spondylitis	0.00171	0.00277	CcSEcCtD
Ipratropium bromide—Eye disorder—Dexamethasone—ankylosing spondylitis	0.0017	0.00276	CcSEcCtD
Ipratropium bromide—Eye disorder—Betamethasone—ankylosing spondylitis	0.0017	0.00276	CcSEcCtD
Ipratropium bromide—Back pain—Triamcinolone—ankylosing spondylitis	0.00169	0.00274	CcSEcCtD
Ipratropium bromide—Asthma—Methotrexate—ankylosing spondylitis	0.00166	0.00268	CcSEcCtD
Ipratropium bromide—Hypertension—Prednisolone—ankylosing spondylitis	0.00164	0.00266	CcSEcCtD
Ipratropium bromide—Angioedema—Triamcinolone—ankylosing spondylitis	0.0016	0.00259	CcSEcCtD
Ipratropium bromide—Haemoglobin—Prednisone—ankylosing spondylitis	0.0016	0.00258	CcSEcCtD
Ipratropium bromide—Angioedema—Methylprednisolone—ankylosing spondylitis	0.0016	0.00258	CcSEcCtD
Ipratropium bromide—Abdominal discomfort—Methotrexate—ankylosing spondylitis	0.00159	0.00257	CcSEcCtD
Ipratropium bromide—Haemorrhage—Prednisone—ankylosing spondylitis	0.00159	0.00257	CcSEcCtD
Ipratropium bromide—Oedema—Prednisolone—ankylosing spondylitis	0.00155	0.00251	CcSEcCtD
Ipratropium bromide—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.00155	0.00251	CcSEcCtD
Ipratropium bromide—Dysuria—Methotrexate—ankylosing spondylitis	0.00155	0.00251	CcSEcCtD
Ipratropium bromide—Upper respiratory tract infection—Methotrexate—ankylosing spondylitis	0.00154	0.00249	CcSEcCtD
Ipratropium bromide—Cough—Triamcinolone—ankylosing spondylitis	0.00153	0.00247	CcSEcCtD
Ipratropium bromide—Tachycardia—Prednisolone—ankylosing spondylitis	0.00152	0.00245	CcSEcCtD
Ipratropium bromide—Hypertension—Triamcinolone—ankylosing spondylitis	0.00151	0.00244	CcSEcCtD
Ipratropium bromide—Hypertension—Methylprednisolone—ankylosing spondylitis	0.00151	0.00244	CcSEcCtD
Ipratropium bromide—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.0015	0.00243	CcSEcCtD
Ipratropium bromide—Myalgia—Triamcinolone—ankylosing spondylitis	0.00149	0.00241	CcSEcCtD
Ipratropium bromide—Myalgia—Methylprednisolone—ankylosing spondylitis	0.00149	0.0024	CcSEcCtD
Ipratropium bromide—Eye disorder—Prednisone—ankylosing spondylitis	0.00148	0.0024	CcSEcCtD
Ipratropium bromide—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.00148	0.00239	CcSEcCtD
Ipratropium bromide—Flushing—Prednisone—ankylosing spondylitis	0.00147	0.00238	CcSEcCtD
Ipratropium bromide—Dry mouth—Triamcinolone—ankylosing spondylitis	0.00146	0.00236	CcSEcCtD
Ipratropium bromide—Angioedema—Dexamethasone—ankylosing spondylitis	0.00145	0.00235	CcSEcCtD
Ipratropium bromide—Angioedema—Betamethasone—ankylosing spondylitis	0.00145	0.00235	CcSEcCtD
Ipratropium bromide—Stomatitis—Methotrexate—ankylosing spondylitis	0.00144	0.00233	CcSEcCtD
Ipratropium bromide—Conjunctivitis—Methotrexate—ankylosing spondylitis	0.00144	0.00232	CcSEcCtD
Ipratropium bromide—Immune system disorder—Prednisone—ankylosing spondylitis	0.00143	0.00232	CcSEcCtD
Ipratropium bromide—Oedema—Triamcinolone—ankylosing spondylitis	0.00143	0.00231	CcSEcCtD
Ipratropium bromide—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.00143	0.00231	CcSEcCtD
Ipratropium bromide—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.00142	0.0023	CcSEcCtD
Ipratropium bromide—Infection—Triamcinolone—ankylosing spondylitis	0.00142	0.00229	CcSEcCtD
Ipratropium bromide—Sweating—Methotrexate—ankylosing spondylitis	0.00142	0.00229	CcSEcCtD
Ipratropium bromide—Infection—Methylprednisolone—ankylosing spondylitis	0.00142	0.00229	CcSEcCtD
Ipratropium bromide—Insomnia—Prednisolone—ankylosing spondylitis	0.0014	0.00227	CcSEcCtD
Ipratropium bromide—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.0014	0.00226	CcSEcCtD
Ipratropium bromide—Epistaxis—Methotrexate—ankylosing spondylitis	0.00139	0.00226	CcSEcCtD
Ipratropium bromide—Paraesthesia—Prednisolone—ankylosing spondylitis	0.00139	0.00225	CcSEcCtD
Ipratropium bromide—Tachycardia—Triamcinolone—ankylosing spondylitis	0.00139	0.00225	CcSEcCtD
Ipratropium bromide—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.00139	0.00225	CcSEcCtD
Ipratropium bromide—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.00138	0.00224	CcSEcCtD
Ipratropium bromide—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.00138	0.00223	CcSEcCtD
Ipratropium bromide—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.00138	0.00223	CcSEcCtD
Ipratropium bromide—Hypertension—Dexamethasone—ankylosing spondylitis	0.00137	0.00222	CcSEcCtD
Ipratropium bromide—Hypertension—Betamethasone—ankylosing spondylitis	0.00137	0.00222	CcSEcCtD
Ipratropium bromide—Myalgia—Dexamethasone—ankylosing spondylitis	0.00135	0.00219	CcSEcCtD
Ipratropium bromide—Myalgia—Betamethasone—ankylosing spondylitis	0.00135	0.00219	CcSEcCtD
Ipratropium bromide—Haemoglobin—Methotrexate—ankylosing spondylitis	0.00133	0.00216	CcSEcCtD
Ipratropium bromide—Hypotension—Methylprednisolone—ankylosing spondylitis	0.00133	0.00215	CcSEcCtD
Ipratropium bromide—Pain—Prednisolone—ankylosing spondylitis	0.00133	0.00215	CcSEcCtD
Ipratropium bromide—Haemorrhage—Methotrexate—ankylosing spondylitis	0.00133	0.00215	CcSEcCtD
Ipratropium bromide—Pharyngitis—Methotrexate—ankylosing spondylitis	0.00132	0.00213	CcSEcCtD
Ipratropium bromide—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.00131	0.00212	CcSEcCtD
Ipratropium bromide—Vision blurred—Prednisone—ankylosing spondylitis	0.0013	0.00211	CcSEcCtD
Ipratropium bromide—Urethral disorder—Methotrexate—ankylosing spondylitis	0.0013	0.0021	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.0013	0.0021	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.0013	0.0021	CcSEcCtD
Ipratropium bromide—Oedema—Dexamethasone—ankylosing spondylitis	0.0013	0.0021	CcSEcCtD
Ipratropium bromide—Oedema—Betamethasone—ankylosing spondylitis	0.0013	0.0021	CcSEcCtD
Ipratropium bromide—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.0013	0.0021	CcSEcCtD
Ipratropium bromide—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.0013	0.0021	CcSEcCtD
Ipratropium bromide—Insomnia—Triamcinolone—ankylosing spondylitis	0.00129	0.00209	CcSEcCtD
Ipratropium bromide—Insomnia—Methylprednisolone—ankylosing spondylitis	0.00129	0.00208	CcSEcCtD
Ipratropium bromide—Infection—Dexamethasone—ankylosing spondylitis	0.00129	0.00208	CcSEcCtD
Ipratropium bromide—Infection—Betamethasone—ankylosing spondylitis	0.00129	0.00208	CcSEcCtD
Ipratropium bromide—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.00128	0.00207	CcSEcCtD
Ipratropium bromide—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.00128	0.00207	CcSEcCtD
Ipratropium bromide—Visual impairment—Methotrexate—ankylosing spondylitis	0.00128	0.00207	CcSEcCtD
Ipratropium bromide—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.00127	0.00206	CcSEcCtD
Ipratropium bromide—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.00127	0.00205	CcSEcCtD
Ipratropium bromide—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.00127	0.00205	CcSEcCtD
Ipratropium bromide—Tachycardia—Dexamethasone—ankylosing spondylitis	0.00126	0.00204	CcSEcCtD
Ipratropium bromide—Tachycardia—Betamethasone—ankylosing spondylitis	0.00126	0.00204	CcSEcCtD
Ipratropium bromide—Angioedema—Prednisone—ankylosing spondylitis	0.00126	0.00204	CcSEcCtD
Ipratropium bromide—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.00126	0.00203	CcSEcCtD
Ipratropium bromide—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.00125	0.00203	CcSEcCtD
Ipratropium bromide—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.00125	0.00203	CcSEcCtD
Ipratropium bromide—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.00125	0.00203	CcSEcCtD
Ipratropium bromide—Eye disorder—Methotrexate—ankylosing spondylitis	0.00124	0.00201	CcSEcCtD
Ipratropium bromide—Tinnitus—Methotrexate—ankylosing spondylitis	0.00124	0.002	CcSEcCtD
Ipratropium bromide—Urticaria—Prednisolone—ankylosing spondylitis	0.00123	0.00199	CcSEcCtD
Ipratropium bromide—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.00123	0.00199	CcSEcCtD
Ipratropium bromide—Fatigue—Triamcinolone—ankylosing spondylitis	0.00123	0.00199	CcSEcCtD
Ipratropium bromide—Fatigue—Methylprednisolone—ankylosing spondylitis	0.00123	0.00199	CcSEcCtD
Ipratropium bromide—Pain—Triamcinolone—ankylosing spondylitis	0.00122	0.00197	CcSEcCtD
Ipratropium bromide—Hypotension—Betamethasone—ankylosing spondylitis	0.00121	0.00196	CcSEcCtD
Ipratropium bromide—Hypotension—Dexamethasone—ankylosing spondylitis	0.00121	0.00196	CcSEcCtD
Ipratropium bromide—Immune system disorder—Methotrexate—ankylosing spondylitis	0.0012	0.00194	CcSEcCtD
Ipratropium bromide—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.0012	0.00193	CcSEcCtD
Ipratropium bromide—Hypertension—Prednisone—ankylosing spondylitis	0.00119	0.00193	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.00118	0.00191	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.00118	0.00191	CcSEcCtD
Ipratropium bromide—Myalgia—Prednisone—ankylosing spondylitis	0.00118	0.0019	CcSEcCtD
Ipratropium bromide—Insomnia—Dexamethasone—ankylosing spondylitis	0.00117	0.0019	CcSEcCtD
Ipratropium bromide—Insomnia—Betamethasone—ankylosing spondylitis	0.00117	0.0019	CcSEcCtD
Ipratropium bromide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.00117	0.00189	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.00116	0.00188	CcSEcCtD
Ipratropium bromide—Paraesthesia—Betamethasone—ankylosing spondylitis	0.00116	0.00188	CcSEcCtD
Ipratropium bromide—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.00116	0.00188	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.00114	0.00185	CcSEcCtD
Ipratropium bromide—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.00114	0.00184	CcSEcCtD
Ipratropium bromide—Dyspepsia—Betamethasone—ankylosing spondylitis	0.00114	0.00184	CcSEcCtD
Ipratropium bromide—Urticaria—Triamcinolone—ankylosing spondylitis	0.00113	0.00183	CcSEcCtD
Ipratropium bromide—Urticaria—Methylprednisolone—ankylosing spondylitis	0.00113	0.00183	CcSEcCtD
Ipratropium bromide—Dysgeusia—Methotrexate—ankylosing spondylitis	0.00113	0.00183	CcSEcCtD
Ipratropium bromide—Oedema—Prednisone—ankylosing spondylitis	0.00113	0.00182	CcSEcCtD
Ipratropium bromide—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.00113	0.00182	CcSEcCtD
Ipratropium bromide—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.00113	0.00182	CcSEcCtD
Ipratropium bromide—Infection—Prednisone—ankylosing spondylitis	0.00112	0.00181	CcSEcCtD
Ipratropium bromide—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.00112	0.00181	CcSEcCtD
Ipratropium bromide—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.00112	0.00181	CcSEcCtD
Ipratropium bromide—Back pain—Methotrexate—ankylosing spondylitis	0.00112	0.00181	CcSEcCtD
Ipratropium bromide—Fatigue—Dexamethasone—ankylosing spondylitis	0.00112	0.00181	CcSEcCtD
Ipratropium bromide—Fatigue—Betamethasone—ankylosing spondylitis	0.00112	0.00181	CcSEcCtD
Ipratropium bromide—Pain—Dexamethasone—ankylosing spondylitis	0.00111	0.00179	CcSEcCtD
Ipratropium bromide—Pain—Betamethasone—ankylosing spondylitis	0.00111	0.00179	CcSEcCtD
Ipratropium bromide—Nervous system disorder—Prednisone—ankylosing spondylitis	0.00111	0.00179	CcSEcCtD
Ipratropium bromide—Tachycardia—Prednisone—ankylosing spondylitis	0.0011	0.00178	CcSEcCtD
Ipratropium bromide—Skin disorder—Prednisone—ankylosing spondylitis	0.0011	0.00177	CcSEcCtD
Ipratropium bromide—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.00109	0.00176	CcSEcCtD
Ipratropium bromide—Vision blurred—Methotrexate—ankylosing spondylitis	0.00109	0.00176	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.00106	0.00171	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.00106	0.00171	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.00105	0.0017	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.00105	0.0017	CcSEcCtD
Ipratropium bromide—Urticaria—Dexamethasone—ankylosing spondylitis	0.00103	0.00166	CcSEcCtD
Ipratropium bromide—Urticaria—Betamethasone—ankylosing spondylitis	0.00103	0.00166	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.00103	0.00166	CcSEcCtD
Ipratropium bromide—Dizziness—Prednisolone—ankylosing spondylitis	0.00103	0.00166	CcSEcCtD
Ipratropium bromide—Asthenia—Triamcinolone—ankylosing spondylitis	0.00102	0.00166	CcSEcCtD
Ipratropium bromide—Abdominal pain—Betamethasone—ankylosing spondylitis	0.00102	0.00166	CcSEcCtD
Ipratropium bromide—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.00102	0.00166	CcSEcCtD
Ipratropium bromide—Asthenia—Methylprednisolone—ankylosing spondylitis	0.00102	0.00165	CcSEcCtD
Ipratropium bromide—Insomnia—Prednisone—ankylosing spondylitis	0.00102	0.00165	CcSEcCtD
Ipratropium bromide—Paraesthesia—Prednisone—ankylosing spondylitis	0.00101	0.00164	CcSEcCtD
Ipratropium bromide—Pruritus—Triamcinolone—ankylosing spondylitis	0.00101	0.00163	CcSEcCtD
Ipratropium bromide—Cough—Methotrexate—ankylosing spondylitis	0.00101	0.00163	CcSEcCtD
Ipratropium bromide—Pruritus—Methylprednisolone—ankylosing spondylitis	0.00101	0.00163	CcSEcCtD
Ipratropium bromide—Dyspepsia—Prednisone—ankylosing spondylitis	0.000993	0.00161	CcSEcCtD
Ipratropium bromide—Myalgia—Methotrexate—ankylosing spondylitis	0.000984	0.00159	CcSEcCtD
Ipratropium bromide—Chest pain—Methotrexate—ankylosing spondylitis	0.000984	0.00159	CcSEcCtD
Ipratropium bromide—Rash—Prednisolone—ankylosing spondylitis	0.000979	0.00158	CcSEcCtD
Ipratropium bromide—Dermatitis—Prednisolone—ankylosing spondylitis	0.000978	0.00158	CcSEcCtD
Ipratropium bromide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000977	0.00158	CcSEcCtD
Ipratropium bromide—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000975	0.00158	CcSEcCtD
Ipratropium bromide—Fatigue—Prednisone—ankylosing spondylitis	0.000973	0.00157	CcSEcCtD
Ipratropium bromide—Headache—Prednisolone—ankylosing spondylitis	0.000973	0.00157	CcSEcCtD
Ipratropium bromide—Constipation—Prednisone—ankylosing spondylitis	0.000965	0.00156	CcSEcCtD
Ipratropium bromide—Dizziness—Triamcinolone—ankylosing spondylitis	0.000944	0.00153	CcSEcCtD
Ipratropium bromide—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.000943	0.00153	CcSEcCtD
Ipratropium bromide—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000942	0.00152	CcSEcCtD
Ipratropium bromide—Infection—Methotrexate—ankylosing spondylitis	0.000937	0.00152	CcSEcCtD
Ipratropium bromide—Asthenia—Dexamethasone—ankylosing spondylitis	0.00093	0.0015	CcSEcCtD
Ipratropium bromide—Asthenia—Betamethasone—ankylosing spondylitis	0.00093	0.0015	CcSEcCtD
Ipratropium bromide—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000925	0.0015	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000923	0.00149	CcSEcCtD
Ipratropium bromide—Nausea—Prednisolone—ankylosing spondylitis	0.000922	0.00149	CcSEcCtD
Ipratropium bromide—Pruritus—Betamethasone—ankylosing spondylitis	0.000917	0.00148	CcSEcCtD
Ipratropium bromide—Pruritus—Dexamethasone—ankylosing spondylitis	0.000917	0.00148	CcSEcCtD
Ipratropium bromide—Skin disorder—Methotrexate—ankylosing spondylitis	0.000916	0.00148	CcSEcCtD
Ipratropium bromide—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.000912	0.00147	CcSEcCtD
Ipratropium bromide—Vomiting—Triamcinolone—ankylosing spondylitis	0.000908	0.00147	CcSEcCtD
Ipratropium bromide—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000906	0.00147	CcSEcCtD
Ipratropium bromide—Rash—Triamcinolone—ankylosing spondylitis	0.0009	0.00146	CcSEcCtD
Ipratropium bromide—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000899	0.00145	CcSEcCtD
Ipratropium bromide—Rash—Methylprednisolone—ankylosing spondylitis	0.000898	0.00145	CcSEcCtD
Ipratropium bromide—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000897	0.00145	CcSEcCtD
Ipratropium bromide—Urticaria—Prednisone—ankylosing spondylitis	0.000896	0.00145	CcSEcCtD
Ipratropium bromide—Headache—Triamcinolone—ankylosing spondylitis	0.000894	0.00145	CcSEcCtD
Ipratropium bromide—Headache—Methylprednisolone—ankylosing spondylitis	0.000892	0.00144	CcSEcCtD
Ipratropium bromide—Abdominal pain—Prednisone—ankylosing spondylitis	0.000892	0.00144	CcSEcCtD
Ipratropium bromide—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000886	0.00143	CcSEcCtD
Ipratropium bromide—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000886	0.00143	CcSEcCtD
Ipratropium bromide—Hypotension—Methotrexate—ankylosing spondylitis	0.000881	0.00143	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000859	0.00139	CcSEcCtD
Ipratropium bromide—Dizziness—Betamethasone—ankylosing spondylitis	0.000857	0.00139	CcSEcCtD
Ipratropium bromide—Dizziness—Dexamethasone—ankylosing spondylitis	0.000857	0.00139	CcSEcCtD
Ipratropium bromide—Insomnia—Methotrexate—ankylosing spondylitis	0.000853	0.00138	CcSEcCtD
Ipratropium bromide—Nausea—Triamcinolone—ankylosing spondylitis	0.000848	0.00137	CcSEcCtD
Ipratropium bromide—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000847	0.00137	CcSEcCtD
Ipratropium bromide—Nausea—Methylprednisolone—ankylosing spondylitis	0.000846	0.00137	CcSEcCtD
Ipratropium bromide—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000841	0.00136	CcSEcCtD
Ipratropium bromide—Somnolence—Methotrexate—ankylosing spondylitis	0.000838	0.00136	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000831	0.00134	CcSEcCtD
Ipratropium bromide—Dyspepsia—Methotrexate—ankylosing spondylitis	0.00083	0.00134	CcSEcCtD
Ipratropium bromide—Vomiting—Betamethasone—ankylosing spondylitis	0.000824	0.00133	CcSEcCtD
Ipratropium bromide—Vomiting—Dexamethasone—ankylosing spondylitis	0.000824	0.00133	CcSEcCtD
Ipratropium bromide—Rash—Betamethasone—ankylosing spondylitis	0.000817	0.00132	CcSEcCtD
Ipratropium bromide—Rash—Dexamethasone—ankylosing spondylitis	0.000817	0.00132	CcSEcCtD
Ipratropium bromide—Dermatitis—Betamethasone—ankylosing spondylitis	0.000816	0.00132	CcSEcCtD
Ipratropium bromide—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000816	0.00132	CcSEcCtD
Ipratropium bromide—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000814	0.00132	CcSEcCtD
Ipratropium bromide—Fatigue—Methotrexate—ankylosing spondylitis	0.000813	0.00131	CcSEcCtD
Ipratropium bromide—Headache—Dexamethasone—ankylosing spondylitis	0.000812	0.00131	CcSEcCtD
Ipratropium bromide—Headache—Betamethasone—ankylosing spondylitis	0.000812	0.00131	CcSEcCtD
Ipratropium bromide—Asthenia—Prednisone—ankylosing spondylitis	0.000809	0.00131	CcSEcCtD
Ipratropium bromide—Pain—Methotrexate—ankylosing spondylitis	0.000806	0.0013	CcSEcCtD
Ipratropium bromide—Pruritus—Prednisone—ankylosing spondylitis	0.000798	0.00129	CcSEcCtD
Ipratropium bromide—Diarrhoea—Prednisone—ankylosing spondylitis	0.000772	0.00125	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000771	0.00125	CcSEcCtD
Ipratropium bromide—Nausea—Betamethasone—ankylosing spondylitis	0.00077	0.00124	CcSEcCtD
Ipratropium bromide—Nausea—Dexamethasone—ankylosing spondylitis	0.00077	0.00124	CcSEcCtD
Ipratropium bromide—Urticaria—Methotrexate—ankylosing spondylitis	0.000749	0.00121	CcSEcCtD
Ipratropium bromide—Dizziness—Prednisone—ankylosing spondylitis	0.000746	0.00121	CcSEcCtD
Ipratropium bromide—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000745	0.00121	CcSEcCtD
Ipratropium bromide—Vomiting—Prednisone—ankylosing spondylitis	0.000717	0.00116	CcSEcCtD
Ipratropium bromide—Rash—Prednisone—ankylosing spondylitis	0.000711	0.00115	CcSEcCtD
Ipratropium bromide—Dermatitis—Prednisone—ankylosing spondylitis	0.000711	0.00115	CcSEcCtD
Ipratropium bromide—Headache—Prednisone—ankylosing spondylitis	0.000707	0.00114	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000695	0.00112	CcSEcCtD
Ipratropium bromide—Asthenia—Methotrexate—ankylosing spondylitis	0.000677	0.00109	CcSEcCtD
Ipratropium bromide—Nausea—Prednisone—ankylosing spondylitis	0.00067	0.00108	CcSEcCtD
Ipratropium bromide—Pruritus—Methotrexate—ankylosing spondylitis	0.000667	0.00108	CcSEcCtD
Ipratropium bromide—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000645	0.00104	CcSEcCtD
Ipratropium bromide—Dizziness—Methotrexate—ankylosing spondylitis	0.000624	0.00101	CcSEcCtD
Ipratropium bromide—Vomiting—Methotrexate—ankylosing spondylitis	0.0006	0.00097	CcSEcCtD
Ipratropium bromide—Rash—Methotrexate—ankylosing spondylitis	0.000595	0.000962	CcSEcCtD
Ipratropium bromide—Dermatitis—Methotrexate—ankylosing spondylitis	0.000594	0.000961	CcSEcCtD
Ipratropium bromide—Headache—Methotrexate—ankylosing spondylitis	0.000591	0.000955	CcSEcCtD
Ipratropium bromide—Nausea—Methotrexate—ankylosing spondylitis	0.00056	0.000906	CcSEcCtD
